Andrews Nancy C
SEC CIK 1804999 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CRL | Charles River Laboratories | Dir | 2,011 | — | $163.4K | 9 | 2022-05-11 | 2026-08-18 |
Most active insiders at CRL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FOSTER JAMES C | Dir | — | $34.84M |
| 2 | Parisotto Shannon M | CEVP, Disc, Safety Assessment | — | $2.97M |
| 3 | Girshick Birgit | COO, Corp. Executive VP | — | $1.82M |
| 4 | Knell Michael Gunnar | SVP, CAO, Fin | — | $1.73M |
| 5 | Creamer Victoria L | EVP, CHRO | — | $1.08M |
| 6 | Andrews Nancy C | Dir | — | $163.4K |
| 7 | LaPlume Joseph W | EVP, Corp Strategy, Develop | $4,364 | — |
| 8 | Mintz Mark | EVP, CIO | — | — |
| 9 | Kemps-Polanco Reshema | Dir | — | — |
| 10 | Barg Steven | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-20 16:31 | 2026-08-18 | CRL | Charles River Laboratories | Andrews Nancy C | Dir | M - OptEx | $164.30 | +573 | 2,011 | +40% | +$94.1K |
| D | 2026-08-20 16:31 | 2026-08-18 | CRL | Charles River Laboratories | Andrews Nancy C | Dir | S - Sale+OE | $285.24 | -573 | 1,438 | -28% | -$163.4K |
| 2026-05-14 17:11 | 2026-05-12 | CRL | Charles River Laboratories | Andrews Nancy C | Dir | G - Gift | $0.00 | -3,964 | 1,438 | -73% | $0 | |
| I | 2026-05-14 17:11 | 2026-05-12 | CRL | Charles River Laboratories | Andrews Nancy C | Dir | G - Gift | $0.00 | +3,964 | 3,964 | New | $0 |
| 2026-05-11 16:45 | 2026-05-08 | CRL | Charles River Laboratories | Andrews Nancy C | Dir | A - Grant | $177.62 | +1,438 | 5,402 | +36% | +$255.4K | |
| D | 2025-05-23 | 2025-05-21 | CRL | Charles River Laboratories | Andrews Nancy C | Dir | A - Grant | $134.98 | +946 | 3,964 | +31% | +$127.7K |
| D | 2024-05-15 | 2024-05-13 | CRL | Charles River Laboratories | Andrews Nancy C | Dir | A - Grant | $228.41 | +559 | 3,018 | +23% | +$127.7K |
| D | 2023-05-17 | 2023-05-15 | CRL | Charles River Laboratories | Andrews Nancy C | Dir | A - Grant | $0.00 | +664 | 2,459 | +37% | $0 |
| D | 2022-05-13 | 2022-05-11 | CRL | Charles River Laboratories | Andrews Nancy C | Dir | A - Grant | $0.00 | +575 | 1,795 | +47% | $0 |
Purchase Sale Sale after option exercise All abbreviations